Our research focus
Cell and gene therapy
The evolution of medicines from small molecules to proteins drove increased therapeutic benefits, and the next generation of cell and gene therapies holds tremendous promise for patients. Oncode researchers pioneered the advancement of novel technologies in this arena.
Please drop us a line if you want to get in touch with one of our experts.
Oncode Investigators
-
Carl Figdor Group (Radboud UMC)
Chemical Immunology, antigen presenting cells, Immunotherapy -
Leila Akkari Group (NKI)
Immune cells and macrophages in therapeutically challenging tumors -
Monika Wolkers Group (Sanquin)
T cell effector function, post-transcriptional gene regulation, RNA binding proteins